Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20210419051016N3Phase 3Completed
Phase 3, randomised, open-label trial of tranexamic acid in postoperative hemorrhage (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Intensity of bleeding and Bleeding time. Started Apr 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20210419051016N3.